The Biggest Pharma Stock Blowups Of 2016

Novavax, Inc. NVAX 10.82%’s massive 84.5 percent Friday blowup was certainly a shock for biotech investors. However, in an industry where a company’s fate can lie primarily in a single drug candidate, blowups like Novavax’s happen all too frequently. Here’s a look at five of the biggest one-day biotech blow-ups of 2016.

image4

The Federal Reserve’s Stress Tests May Be Illegal

A new paper by the nonprofit Committee on Capital Markets Regulation (CCMR) suggests that banks subject to the Federal Reserve’s annual stress tests and CCAR could have grounds for a lawsuit against the government. The CCMR includes senior management representatives from JPMorgan Chase & Co. JPM 0.41%, Citigroup Inc C 0.11%,Goldman Sachs Group Inc GS…